Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease

Molecular Pharmacology

Volumn 57, Issue 2, 2000, Pages 409-417

  Camps, Pelayo ^b   Cusack, Bernadette ^a   Mallender, William D ^a   El Achab, Rachid ^b   Morral, Jordi ^b   Muñoz Torrero, Diego ^b   Rosenberry, Terrone L ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; EDROPHONIUM; HUPERZINE A; HUPRINE X; TACRINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; CHOLINESTERASE INHIBITION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SYNTHESIS; ENZYME ACTIVE SITE; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; ACYLATION; ALZHEIMER DISEASE; AMINOQUINOLINES; BINDING, COMPETITIVE; CHOLINESTERASE INHIBITORS; ERYTHROCYTES; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; INTERCALATING AGENTS; KINETICS; PROPIDIUM;

EID: 0033966913     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Badia A, Baños JE, Camps P, Contreras J, Görbig DM, Muñoz-Torrero D, Simón M and Vivas NM (1998) Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease. Bioorg Med Chem 6:427-440.
2. Barak D, Kronman C, Ordentlich A, Ariel N, Bromberg A, Marcus D, Lazar A, Velan B and Shafferman A (1994) Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core. J Biol Chem 269:6296-6305.
3. Barril X, Orozco M and Luque FJ (1999) Predicting relative binding free energies of tacrine-huperzine A hybrids as inhibitors of acetylcholinesterase. J Med Chem 42:5110-5119.
4. Bartus R, Dean R, Beer B and Lippa A (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science (Wash DC) 217:408-417.
5. Bourne Y, Taylor P and Marchot P (1995) Acetylcholinesterase inhibition by fasciculin: Crystal structure of the complex. Cell 83:503-512.
6. Bowen DM, Benton JS, Spillane JA, Smith CC and Allen SJ (1982) Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J Neurol Sci 57:191-202.
7. Camps P, Contreras J, Font-Bardia M, Morral J, Muñoz-Torrero D and Solans X (1998) Enantioselective synthesis of tacrine-huperzine A hybrids. Preparative chiral MPLC separation of their racemic mixtures and absolute configuration assignments by X-ray diffraction analysis. Tetrahedron: Asymmetry 9:835-849.
8. Camps P, El Achab R, Font-Bardia M, Görbig D, Morral J, Muñoz-Torrero D, Solans X and Simon M (1996) Easy synthesis of 7-alkylbicyclo[3.3.1]non-6-en-3-ones by silica gel-promoted fragmentation of 3-alkyl-2-oxaadamant-1-yl mesylates. Tetrahedron 52:5867-5880.
9. Camps P, El Achab R, Görbig DM, Morral J, Muñoz-Torrero D, Badia A, Baños JE, Vivas NM, Barril X, Orozco M and Luque FJ (1999) Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease. J Med Chem 42:3227-3242.
10. Davies P and Maloney AJF (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2:1403.
11. Eastman J, Wilson EJ, Cervenansky C and Rosenberry TL (1995) Fasciculin 2 binds to a peripheral site on acetylcholinesterase and inhibits substrate hydrolysis by slowing a step involving proton transfer during enzyme acylation. J Biol Chem 270:19694-19701.
12. Ellman GL, Courtney KD, Andres JV and Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95.
13. Harel M, Kleywegt GJ, Ravelli RBG, Silman I and Sussman JL (1995) Crystal structure of an acetylcholinesterase-fasciculin complex: Interaction of a three-fingered toxin from snake venom with its target. Structure 3:1355-1366.
14. Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I and Sussman JL (1993) Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci USA 90:9031-9035.
15. Hodge AS, Humphrey DR and Rosenberry TL (1992) Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase with one of the highest known affinities. Mol Pharmacol 41:937-942.
16. Incardona JP and Rosenberry TL (1996) Construction and characterization of secreted and chimeric transmembrane forms of Drosophila acetylcholinesterase: A large truncation of the C-terminal signal peptide does not eliminate glycoinositol phospholipid anchoring. Mol Biol Cell 7:595-611.
17. Kozikowski AP, Thiels E, Tang X-C and Hanin I (1992) Huperzine A-A possible lead structure in the treatment of Alzheimer's disease. Adv Med Chem 1:175-205.
18. Lockridge O (1990) Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol Ther 47:35-60.
19. Mallender WD, Szegletes T and Rosenberry TL (1999) Organophosphorylation of acetylcholinesterase in the presence of peripheral site ligands: Distinct effects of propidium and fasciculin. J Biol Chem 274:8491-8499.
20. Muramoto O, Sugishita M, Sugita H and Toyokura Y (1979) Effect of physostigmine on constructional and memory tasks in Alzheimer's disease. Arch Neurol 36:501-503.
21. Nair HK, Lee K and Quinn DM (1993) m-(N,N, N-Trimethylammonio)trifluoroacetophenone: A femtomolar inhibitor of acetylcholinesterase. J Am Chem Soc 115: 9939-9941.
22. Pang Y-P, Quiram P, Jelacic T, Hong F and Brimijoin S (1996) Highly potent selective and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. J Biol Chem 271:23646-23649.
23. Perry EK, Perry TH, Blessed G and Tomlinson BE (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1:189.
24. Raves ML, Harel M, Pang Y-P, Silman I, Kozikowski AP and Sussman JL (1997) Structure of acetylcholinesterase complexed with the nootropic alkaloid (-)-huperzine A. Nat Struct Biol 4:57-63.
25. Riddles PW, Blakeley RL and Zerner B (1979) Ellman's reagent: 5, 5′-dithiobis-(2-nitrobenzoic) acid - A reexamination. Anal Biochem 94:75-81.
26. Roberts WL, Kim BH and Rosenberry TL (1987) Differences in the glycolipid membrane anchors of bovine and human erythrocyte acetylcholinesterases. Proc Natl Acad Sci USA 84:7817-7821.
27. Rosenberry TL (1975) Acetylcholinesterase, in Advances in Enzymology 43 (Meister A ed) pp 103-218, John Wiley & Sons, New York.
28. Rosenberry TL and Bernhard SA (1972) Studies on catalysis by acetylcholinesterase: Synergistic effects of inhibitors during hydrolysis of acetic acid esters. Biochemistry 11:4308-4321.
29. Rosenberry TL, Rabl CR and Neumann E (1996) Binding of the neurotoxin fasciculin 2 to the acetylcholinesterase peripheral site drastically reduces the association and dissociation rate constants for N-methylacridinium binding to the active site. Biochemistry 35:685-690.
30. Rosenberry TL and Scoggin DM (1984) Structure of human erythrocyte acetylcholinesterase. Characterization of intersubunit disulfide bonding and detergent interaction. J Biol Chem 259:5643-5652.
31. Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L and Silman I (1991) Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein. Science (Wash DC) 253:872-879.
32. Szegletes T, Mallender WD and Rosenberry TL (1998) Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands. Biochemistry 37:4206-4216.
33. Szegletes T, Mallender WD, Thomas PJ and Rosenberry TL (1999) Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect. Biochemistry 38:122-133.
34. Taylor P and Lappi S (1975) Interaction of fluorescence probes with acetylcholinesterase: The site and specificity of propidium binding. Biochemistry 14:1989-1997.
35. Whitehouse PJ, Price DL, Clark AW, Coyle JT and DeLong MR (1981) Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122-126.